Cellular Senescence as a Possible Mechanism for Halting Progression of Keloid Lesions

Genes and Cancer

Volumn 2, Issue 11, 2011, Pages 1061-1066

  Varmeh, Shohreh ^b   Egia, Ainara ^a   McGrouther, Duncan ^c   Tahan, Steven R ^a   Bayat, Ardeshir ^c,d   Pandolfi, Pier Paolo ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

keloid; PML; senescence

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL AGING; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA CONTENT; FIBROBLAST; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KELOID; PRIORITY JOURNAL; PROTEIN INDUCTION;

EID: 84868646775     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601912440877     Document Type: Article

References (17)

1. Schafer M,Werner S.Cancer as an overhealing wound: an old hypothesis revisited.Nat Rev Mol Cell Biol. 2008;9 (8): 628-38.
2. Syed F,Ahmadi E,Iqbal SA,Singh S,McGrouther DA,Bayat A.Fibroblasts from the growing margin of Keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy.Br J Dermatol. 2010;164:83-96.
3. Viera MH,Caperton CV,Berman B.Advances in the treatment of keloids.J Drugs Dermatol. 2011;10 (5): 468-80.
4. Shih B,Bayat A.Genetics of keloid scarring.Arch Dermatol Res. 2010;302:319-39.
5. Campisi J,d'Adda di Fagagna F.Cellular senescence: when bad things happen to good cells.Nat Rev Mol Cell Biol. 2007;8 (9): 729-40.
6. Braig M,Lee S,Loddenkemper C, et al.Oncogene-induced senescence as an initial barrier in lymphoma development.Nature. 2005;436 (7051): 660-5.
7. Chen Z,Trotman LC,Shaffer D.Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.Nature. 2005;436 (7051): 725-30.
8. Collado M,Gil J,Efeyan A, et al.Tumour biology: senescence in premalignant tumours.Nature. 2005;436 (7051): 642.
9. Michaloglou C,Vredeveld LC,Soengas MS, et al.BRAFE600-associated senescence-like cell cycle arrest of human naevi.Nature. 2005;436 (7051): 720-4.
10. Diegelmann RF,Cohen IK,McCoy BJ.Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro.J Cell Physiol. 1979;98 (2): 341-6.
11. McCoy BJ,Galdun J,Cohen IK.Effects of density and cellular aging on collagen synthesis and growth kinetics in keloid and normal skin fibroblasts.In Vitro. 1982;18 (1): 79-86.
12. Ferbeyre G,de Stanchina E,Querido E,Baptiste N,Prives C,Lowe SW.PML is induced by oncogenic ras and promotes premature senescence.Genes Dev. 2000;14 (16): 2015-27.
13. Mark Pearson RC,Sebastiani C,Cioce M, et al.PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.Nature. 2000;406 (13): 207-10.
14. Salomoni P,Pandolfi PP.The role of PML in tumor suppression.Cell. 2002;108 (2): 165-70.
15. Jun JI,Lau LF.The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing.Nat Cell Biol. 2010;12 (7): 676-85.
16. Alimonti A,Nardella C,Chen Z, et al.A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis.J Clin Invest. 2010;120 (3): 681-93.
17. Nardella C,Clohessy JG,Alimonti A,Pandolfi PP.Pro-senescence therapy for cancer treatment.Nat Rev Cancer. 2011;11 (7): 503-11.